Clinical Trial: A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS)

U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07722988) titled 'A Study to Investigate the Efficacy and Safety of Roxadustat (FG-4592) for Treating Anemia in Participants With Myelodysplastic Syndromes (MDS)' on July 20.

Brief Summary: The study is designed to determine the efficacy and safety of roxadustat for the treatment of anemia due to very low, low, or intermediate risk MDS in participants with high transfusion burden (HTB).

Study Start Date: April, 2027

Study Type: INTERVENTIONAL

Condition: Myelodysplastic Syndromes

Intervention: DRUG: Roxadustat

Roxadustat will be administered per schedule specified in the arm description.

DRUG: Placebo

Placebo matching to roxadustat will be ad...